Chargement en cours...
Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma
Glaucoma is the second leading cause of irreversible blindness and a neurodegenerative disease with a complex pathogenesis. Increasing evidence suggests that oxidative stress and mitochondrial dysfunction have crucial roles in most neurodegenerative diseases such as glaucoma. The conventional clinic...
Enregistré dans:
| Publié dans: | Med Hypothesis Discov Innov Ophthalmol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4921212/ https://ncbi.nlm.nih.gov/pubmed/27350953 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|